News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sablich Kim
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| Sablich Kim (EVP, GM of U.S.) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 2,082 shares
@ $129.73, valued at
$270.1k
|
|
| 03/10/2023 |
4
| Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,752 shares
@ $139.42, valued at
$244.3k
Sold 1,261 shares
@ $140.19, valued at
$176.8k
|
|
| 03/07/2023 |
4
| Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 10,429 shares
@ $0
Paid exercise price by delivering 1,610 shares
@ $142.78, valued at
$229.9k
|
|
| 03/03/2023 |
4
| Sablich Kim (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2021 |
4
| Sablich Kim (EVP & GM, North America) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 2,748 shares
@ $135.0074, valued at
$371k
|
|
| 06/09/2021 |
4
| Sablich Kim (EVP & GM, North America) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,452 shares
@ $176.47, valued at
$256.2k
|
|
| 04/23/2021 |
4
| Sablich Kim (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $8.43, valued at
$210.8k
|
|
| 04/23/2021 |
3
| Sablich Kim (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
| 03/01/2021 |
4
| Sablich Kim (EVP & GM, North America) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 8,535 shares
@ $0 |
|
| 08/07/2020 |
4
| Sablich Kim (EVP & GM, North America) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 16,800 shares
@ $0
Granted 3,144 options to buy
@ $127.07, valued at
$399.5k
Granted 38,856 options to buy
@ $127.07, valued at
$4.9M
|
|
| 06/03/2020 |
3
| Sablich Kim (EVP & GM, North America) has filed a Form 3 on Jazz Pharmaceuticals plc |
| 04/07/2020 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 87,805 shares
@ $0
Granted 134,464 options to buy
@ $8.08, valued at
$1.1M
|
|
| 03/19/2020 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 770 shares
@ $7.38, valued at
$5.7k
Sold 15 shares
@ $6.93, valued at
$104 |
|
| 01/16/2020 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 4,840 shares
@ $14.04, valued at
$68k
|
|
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 37,415 shares
@ $0
Disposed/sold 133,500 options to buy
@ $17.28, valued at
$2.3M
Granted 133,500 options to buy
@ $7.78, valued at
$1M
Disposed/sold 66,130 options to buy
@ $24.44, valued at
$1.6M
Granted 66,130 options to buy
@ $7.78, valued at
$514.5k
|
|
| 04/09/2019 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 66,130 options to buy
@ $24.44, valued at
$1.6M
|
|
| 12/18/2018 |
4
| Sablich Kim (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 29,700 shares
@ $0
Granted 133,500 options to buy
@ $17.28, valued at
$2.3M
|
|
| 12/03/2018 |
3
| Sablich Kim (Chief Commercial Officer) has filed a Form 3 on Myovant Sciences Ltd. |
|
|